NCI Frederick Cancer Research and Development Center (NCI-FCRDC), P.O. Box B, Frederick, Maryland 21702-1201

M -- RECOMPETITION OF THE NCI-FCRDC SYSTEM OF CONTRACTS IN FREDERICK, MARYLAND POC Patricia White, Contract Specialist or John Baker, Contracting -- (301) 846-1113 E-MAIL: http://www.baker@mail.ncifcrf.gov, baker@mail.ncifcrf.gov or whitep@mail.ncifcrf.gov. The National Cancer Institute (NCI) intends to compete the system of contracts for operations and technical support (which includes research and research support), animal production, computer services (small business set-aside), scientific library services (small business set-aside), and a biopharmaceutical development program at the NCI Frederick Cancer Research and Development Center (NCI-FCRDC), a government-owned, contractor-operated facility which is a Federally Funded Research and Development Center (FFRDC). A draft statement of work for the Biopharmaceutical Development Program will be available o/a January 14, 2000. The facility consists of approximately 100 buildings and structures on approximately 70 acres in Frederick, Maryland. The NCI intends to recompete this requirement which is presently being performed under four separate contracts as follows: Operations and Technical Support, Contract N01-CO-56000, Science Applications International Corporation; Animal Production, Contract N01-CM-46004, Charles River Laboratories, Inc.; Computer Services, Contract N01-CO-46002, Data Management Services, Inc.; Scientific Library Services, Contract N01-CO-46003, Data Management Services, Inc. All contracts are anticipated to be cost type, either performance based cost-plus-award-fee, or cost-plus-fixed-fee. Offerors will have the option of submitting alternate proposals. The RFP will require that each alternate proposal will be accompanied by a base proposal. Anticipated beginning date of new contracts is September 26, 2001. Further notice to be published, including RFP availability, o/a April, 2000. Term of resulting contract(s) is anticipated to be 5 years. Current annual negotiated amount for the last year of each contract: Operations and Technical Support, $121,370,546; Animal Production, $4,822,994; Computer Services, $3,684,424; Scientific Library Services, $2,185,497. Current operating level for the Biopharmaceutical Development Program is $10-12 million. Announcement is intended to apprise all interested organizations of this future full and open competition opportunity. No collect calls will be accepted. See Numbered Note 2.***** Posted 12/14/99 (W-SN408468). (0348)

Loren Data Corp. http://www.ld.com (SYN# 0056 19991216\M-0003.SOL)